PAT I ENT MONI TORING
to take in all their key data at a glance has dramatically improved workflows and helped to deliver babies back to their parents faster. It has also given time and beds back to the consultants, as decisions are swifter and backed by multiple targeting metrics. With such vulnerable patients at varying levels of stabilisation, the unit also identified the need of more precise individualised targeting. SpO2 target tracking is now defined into precise high and low limits for each baby, through an easy-to-read sliding scale graphic. This level of personalisation and accuracy has improved patient safety at an individual level and allowed staff to track minute changes in saturation levels for a more precise and holistic view of patient performance.
Mindray clinical application specialist Mike Hearnden supported East Kent throughout the configuration and installation process. “We work with very flexible devices, which means customers can choose a high level of customisation,” he commented. I worked closely with the East Kent team to first understand their clinical objectives and preferences, then built on this within the ePM’s range of capabilities. Their specific parameters were configured to obtain and show data in a way determined by their medical team, from graphic displays right down to colour coding.” Twyman added: “Mike was exceptional in sharing his neonatal knowledge and expertise, enabling us to get the full potential from the neonatal saturation screens.” The SCBU can also spot trends and employ precision target tracking monitor for longer periods of time. The ePM’s extensive data storage capabilities allows staff to enter target saturation levels and track patient performance within a selected time duration (up to 48 hours). With such detailed tracking, consultants can review trends and make a more informed discharge decision based on historical data displayed on one screen.
QEQM hospital
By choosing the ePM, the Trust also ensured a smooth and reliable data transfer process with its existing Mindray devices, creating one standardised SpO2 measurement across the Trust in neonatal environments.
Actionable data with proven accuracy
As well as monitoring oxygen saturation levels, the ePM devices also track Perfusion Index (PI) for a pulsatile reading that validates the recorded SpO2 data. This level of validation empowers staff at QEQM to react to the data on screen, reducing the need for further checks and sleep studies in the process. Having greater independence and confidence in decision-making has also limited the potential exposure to delays during the sleep study process.
Along with the neonatal dashboard, target tracking, and the more holistic picture of patient performance, this new level of data accuracy has been recognised and adopted in other parts of the hospital. “The consultant team have been so impressed with the new data that they can review on the ward round each morning that we have now updated our HDU monitors with the same technology,” commented Twyman.
NOVEMBER 2020
Key outcomes East Kent has fundamentally improved patient care for some of its most vulnerable patients, giving parents more time with their new-borns. New babies entering the unit are now supported by a smooth and safe transfer process, involving consistent saturation data which can be easily examined and monitored by staff at the bedside. Upon arrival, custom Sp02 targets can be set for individual babies and tracked through the night for morning analysis, resulting in a faster discharge decision.
Empowering the unit with these actionable saturation readings and customisable targets has improved patient safety at an individual level and as a whole, saving money for the Trust by shortening the average length of stay in the process. After recognising the software’s potential, and the ability to deliver such a significant improvement, the Trust subsequently decided to install the neonatal dashboard on all monitors in its HDU.
Reference 1 NICE, Specialist neonatal respiratory care for babies born preterm, Quality standard [QS193], 15 July 2020.
WWW.CLINICALSERVICESJOURNAL.COM l 63
CSJ
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100
